WO2005042711A9 - Pain-associated gene pnpg1 - Google Patents

Pain-associated gene pnpg1 Download PDF

Info

Publication number
WO2005042711A9
WO2005042711A9 PCT/US2004/035934 US2004035934W WO2005042711A9 WO 2005042711 A9 WO2005042711 A9 WO 2005042711A9 US 2004035934 W US2004035934 W US 2004035934W WO 2005042711 A9 WO2005042711 A9 WO 2005042711A9
Authority
WO
WIPO (PCT)
Prior art keywords
pnpg1
pain
associated gene
gene
gene pnpg1
Prior art date
Application number
PCT/US2004/035934
Other languages
French (fr)
Other versions
WO2005042711A2 (en
Inventor
Lillian W. Chiang
Jiefei Tong
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of WO2005042711A2 publication Critical patent/WO2005042711A2/en
Publication of WO2005042711A9 publication Critical patent/WO2005042711A9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2842Pain, e.g. neuropathic pain, psychogenic pain
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
PCT/US2004/035934 2003-10-28 2004-10-28 Pain-associated gene pnpg1 WO2005042711A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51522403P 2003-10-28 2003-10-28
US60/515,224 2003-10-28

Publications (2)

Publication Number Publication Date
WO2005042711A2 WO2005042711A2 (en) 2005-05-12
WO2005042711A9 true WO2005042711A9 (en) 2010-03-18

Family

ID=34549381

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/035934 WO2005042711A2 (en) 2003-10-28 2004-10-28 Pain-associated gene pnpg1

Country Status (1)

Country Link
WO (1) WO2005042711A2 (en)

Also Published As

Publication number Publication date
WO2005042711A2 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
GB0318428D0 (en) Gene drivers
AU2003273640A1 (en) Autism gene
AU2003294705A1 (en) NtSM GENE
AU2003299467A1 (en) Canine gene microarrays
WO2005042711A9 (en) Pain-associated gene pnpg1
AU2003277902A1 (en) Acc gene
AU2003302040A1 (en) Novel cancer-associated gene
AU2003205812A1 (en) Amp assay
EP1766082B8 (en) Cog47 protein and s100beta gene polymorphism
AU2003241762A1 (en) Dna shuflling
EP1701949B8 (en) Assay for entactogens
AU2003267384A1 (en) Bhyd gene
GB0310457D0 (en) Enzyme
AU2003900232A0 (en) Assay for gene expression ii
AU2003900043A0 (en) Assay for gene expression
AU2003241946A1 (en) Novel acylase gene
AUPR983102A0 (en) Assay for gene expression
AU2003904172A0 (en) Assay
AU2003903691A0 (en) Photobioreactor
AU2003904687A0 (en) An assay
AU2003100006A4 (en) Adcaster
AU2003100198A4 (en) Colourband Browbands
AU2003100325A4 (en) Freez-A-Cube
GB0326598D0 (en) Gene
GB0313773D0 (en) Gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase